The Interactions and Biological Pathways Among Metabolomics Products of Patients with Coronary Heart Disease Analyzed Using the Bioinformatics Methods

Author:

Chu Chun1,Liu Shengquan1,Nie Liangui1,Hu Hongming1,Liu Yi1,Yang Jun1

Affiliation:

1. University of South China

Abstract

Abstract Background: Metabolome products are small molecules resulting from cellular metabolism. Studies has used advanced methods of molecular detection to analysis samples of ill patients. Based on bioinformatics analysis, the interactions and biological pathways among metabolome products in patients with coronary heart disease (CHD) were investigated. Methods: Related studies focusing on the metabolomics analysis of patients with CHD published on CNKI, Wanfang, VIP, CBM, PubMed, Cochrane Library, Nature, Web of Science, Spring, and Science Direct were retrieved. The metabolites in the literature were analyzed statistically and summarized, the differential metabolites were selected and their pathways were analyzed based on the Kyoto Encyclopedia of Genes and Genomes (KEGG). Molecular annotation of metabolites and related enzymes or transporters were analyzed with the HMDB. Their related properties were visualized using the metPA. Results: A total of 12 literatures which satisfying the criteria for enrollment were included here. Total 136 metabolites related to CHD were preliminarily screened, and 83 effective metabolites were obtained after the unrecognized metabolites were excluded. 45 pathways were involved. Through the topology analysis (TPA) of pathways, their influence values were calculated, and 14 major metabolic pathways were selected, which were phenylalanine (Phe), tyrosine and tryptophan biosynthesis (TTB), Aminoacyl-tRNA biosynthesis (ATB), and arginine biosynthesis (ABS). These results indicated that glucose metabolism, fatty acid (FA) metabolism, amino acid (AA) transporting to proteins to cells, and tricarboxylic acid (TCA) cycle were involved in the occurrence of CHD. Conclusion: this study showed cellular and molecular pathways involved in the process of CHD. This information can be used for different drug development and diagnostic studies.

Publisher

Research Square Platform LLC

Reference39 articles.

1. Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging;Katta N;Curr Probl Cardiol,2021

2. Correlation between degenerative aortic valve disease and severity of coronary artery damage in coronary heart disease;He Y;Acta Med Mediterr,2022

3. The effects of exercise training on lipid metabolism and coronary heart disease;Muscella A;Am J Physiol Heart Circ Physiol,2020

4. Diet-derived circulating antioxidants and risk of coronary heart disease: a mendelian randomization study;Luo J;J Am Coll Cardiol,2021

5. Periodontal disease in subjects suffering from coronary heart disease;Mummolo S;J Biol Regul Homeost Agents,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3